.RESEARCH HIGHLIGHT.06 August 2024.
A sizable randomized regulated trial with cisgender women highlights the obstacles of adherence to an everyday dental preexposure prophylaxis regiment and also displays that twice-yearly injection of lenacapavir can maintain efficient HIV deterrence amounts over 6 months.